Our dot blot assay showed that high level of serum ANGPTL4 was associated with vascular invasion and lymph node metastasis (p = 0.0004 and p = 0.006), but not associated with survival time. This evidence concerns the gene ANGPTL4 and metastatic malignant neoplasm in the lymph nodes.